BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Chinese Patent Office

Generated: March 17, 2018

DrugPatentWatch Database Preview

Claims for Patent: 4,589,402

« Back to Dashboard

Summary for Patent: 4,589,402
Title: Method of in vitro fertilization
Abstract:A method of in vitro fertilization therapy, which includes means for inducing ovulation by administering an exogenous human menopausal gonadotropin preparation and human chorionic gonadotropin, harvesting the mature follicles, combining the ovum with spermatazoa in vitro and transferring the conceptus into the uterus is improved by employing FSH as the exogenous human menopausal gonadotropin in the absence of exogenous LH.
Inventor(s): Hodgen; Gary D. (Potomac, MD), Jones, Jr.; Howard W. (Norfolk, VA), Jones; Georgeanna S. (Norfolk, VA)
Assignee: SErono Laboratories, Inc. (Randolph, MA)
Application Number:06/634,697
Patent Claims: 1. In a method of in vitro fertilization which comprises the initial steps of inducing follicular maturation by administering exogeneous human menopausal gonadotropins to a female, inducing ovulation, harvesting the eggs from large ovarian follicles, combining each ovum with spermatozoa in vitro and transferring the conceptus into the uterus, the improvement which consists of employing FSH alone as said exogeneous human menopausal gonadotropin without the presence of exogeneous LH.

2. The method of claim 1, wherein the daily amount of FSH is about 5-10 IU/kg.

3. The method of claim 1, wherein an ovulatory inducing amount of hCG is administered.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Federal Trade Commission
Harvard Business School
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.